Deutsche Bank Ag\ Kymera Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 43,716 shares of KYMR stock, worth $1.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,716

Previous 36,233 20.65%

Holding current value

$1.71 Million

Previous $1.08 Million 91.4%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$30.16 - $52.4 $225,687 - $392,109	7,483 Added 20.65%	43,716 $2.07 Million
Q2 2024 Aug 14, 2024	SELL	$29.85 - $39.42 $168,443 - $222,447	-5,643 Reduced 13.48%	36,233 $1.08 Million
Q1 2024 May 15, 2024	BUY	$22.9 - $43.57 $499,403 - $950,174	21,808 Added 108.67%	41,876 $1.68 Million
Q4 2023 Feb 14, 2024	BUY	$10.97 - $26.84 $2,018 - $4,938	184 Added 0.93%	20,068 $510,000
Q3 2023 Nov 09, 2023	BUY	$13.9 - $23.88 $33,221 - $57,073	2,390 Added 13.66%	19,884 $276,000
Q2 2023 Aug 14, 2023	SELL	$22.4 - $34.92 $172,636 - $269,128	-7,707 Reduced 30.58%	17,494 $402,000
Q1 2023 May 15, 2023	BUY	$24.84 - $38.75 $104,824 - $163,525	4,220 Added 20.11%	25,201 $746,000
Q4 2022 Feb 13, 2023	BUY	$19.57 - $30.92 $97,947 - $154,754	5,005 Added 31.33%	20,981 $523,000
Q3 2022 Nov 14, 2022	SELL	$20.91 - $34.27 $87,822 - $143,934	-4,200 Reduced 20.82%	15,976 $348,000
Q2 2022 Aug 11, 2022	SELL	$14.13 - $42.55 $186,374 - $561,234	-13,190 Reduced 39.53%	20,176 $397,000
Q1 2022 May 13, 2022	SELL	$35.3 - $64.68 $73,565 - $134,793	-2,084 Reduced 5.88%	33,366 $1.41 Million
Q4 2021 Feb 11, 2022	SELL	$49.91 - $65.56 $8,434 - $11,079	-169 Reduced 0.47%	35,450 $2.25 Million
Q3 2021 Nov 04, 2021	BUY	$47.8 - $66.66 $789,608 - $1.1 Million	16,519 Added 86.49%	35,619 $2.09 Million
Q2 2021 Aug 11, 2021	BUY	$31.08 - $51.95 $382,346 - $639,088	12,302 Added 180.96%	19,100 $926,000
Q1 2021 May 13, 2021	SELL	$35.64 - $85.46 $21,811 - $52,301	-612 Reduced 8.26%	6,798 $264,000
Q4 2020 Feb 16, 2021	BUY	$28.07 - $87.83 $207,998 - $650,820	7,410 New	7,410 $460,000

Others Institutions Holding KYMR

# of Institutions

184

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.14B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account